Extended‐fixed vs monthly injections
Proportion of participants with endophthalmitis · people with neovascular age‐related macular degeneration
Extended‐fixed showed no clear difference in endophthalmitis (ocular adverse event) compared with monthly injections (low certainty).
1 finding from 1 review
- Treatment regimens for administration of anti‐vascular endothelial growth factor agents for neovascular age‐related… 2020 · Cochrane Headline outcomes onlyRR 0.19 [0.03, 1.12]3 studies · 1132 participantsLow